AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 282: E1222-E1230, 2002. First published January 22, 2002; doi:10.1152/ajpendo.00324.2001
0193-1849/02 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
282/6/E1222    most recent
00324.2001v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindenthal, B.
Right arrow Articles by Kelleher, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindenthal, B.
Right arrow Articles by Kelleher, J. K.
Vol. 282, Issue 6, E1222-E1230, June 2002

Isotopomer spectral analysis of intermediates of cholesterol synthesis in human subjects and hepatic cells

B. Lindenthal1,2, T. A. Aldaghlas1, A. L. Holleran1, T. Sudhop2, H. K. Berthold2, K. von Bergmann2, and J. K. Kelleher1

1 Department of Physiology, The George Washington University School of Medical and Health Sciences, Washington, District of Columbia 20037; and 2 Department of Clinical Pharmacology, University of Bonn, 53105 Bonn, Germany

Steroid intermediates of the cholesterol synthesis pathway are characterized by rapid turnover rates relative to cholesterol due to their small pool size. Because the small pools will label rapidly, these intermediates may provide valuable information about the incorporation of isotopes in de novo synthesis of cholesterol and related compounds. The labeling of cholesterol synthesis intermediates from [1-13C]acetate was investigated in human subjects and in liver cell models by means of isotopomer spectral analysis (ISA). In human subjects, infusing [1-13C]acetate into the duodenum for 12 h demonstrated that ~50% of the plasma lathosterol pool was derived from de novo synthesis during this interval. The lipogenic acetyl-CoA precursor pool enrichment reached a constant value within 3 h of the start of the infusion. In vitro studies indicated that liver cell models decrease de novo lathosterol synthesis when cholesterol synthesis is inhibited by statins or cholesterol-containing serum. We propose a new calculation to increase the accuracy and precision of cholesterol synthesis estimates in vivo combining the ISA of lathosterol and cholesterol.

lathosterol; lanosterol; desmosterol 13C; tracers; theoretical models; experimental models; simvastatin; pravastatin; stable isotopes





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online